Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model
Fernanda B. de M. Monte, Tadeu L. Montagnoli, Bruno E. Dematté, Fernanda Gubert, Vitória S. Ventura, Jaqueline S. da Silva, Margarete M. Trachez, Rosalia Mendez-Otero, Gisele Zapata-Sudo · 2023
Read Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model by Fernanda B. de M. Monte, Tadeu L. Montagnoli, Bruno E. Dematté, Fernanda Gubert, Vitória S. Ventura, Jaqueline S. da Silva, Margarete M. Trachez, Rosalia Mendez-Otero, Gisele Zapata-Sudo (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10740638.txt.
Description
Chronic pain resists most drugs, and those that work carry heavy side effects, so gentler chemistry is worth hunting. Fernanda Monte and co-authors test a pairing in 2023 that leans on the cholinergic system: a new nicotinic receptor agonist plus donepezil, the Alzheimer's drug that preserves acetylcholine. In rats with a ligated spinal nerve, a model of nerve pain, the pair was dosed together.
The combination reversed pain sensitivity at roughly a tenth of the dose simple additivity predicted, a true synergy. It also calmed spinal cord inflammation, quieting the astrocyte activation that feeds chronic pain. The authors argue the pairing's potency and receptor selectivity could deliver relief with fewer adverse effects.
Catalog record
| CREATOR | Fernanda B. de M. Monte, Tadeu L. Montagnoli, Bruno E. Dematté, Fernanda Gubert, Vitória S. Ventura, Jaqueline S. da Silva, Margarete M. Trachez, Rosalia Mendez-Otero, Gisele Zapata-Sudo |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |